2025
- Precision health in a changing climate
- The changing nature of diagnosis: implications for policy, practice and patients
- Synthetic data for development of AI as a medical device (AIaMDs)
- Optimising EXome PREnatal Sequencing Services (EXPRESS)
2024
- Familial genomic information (goes to external website)
- Host genomics: lessons for infectious disease
2023
- Heat, health and human genetics
- Human involvement in AI-driven digital pathology pathways: ethical and legal considerations
- Workshop report on adopting a risk tool for stratification and predictive prevention of oesophageal cancer
- Are synthetic health data ‘personal data’?
- Evaluation of polygenic score applications
2022
2021
- Control of patient information in the COVID-19 era
- Implementing polygenic scores for cardiovascular disease into NHS Health Checks
- The ethical and legal framework for a Genomics England and Sano Genetics participant engagement platform
- Polygenic scores and clinical utility
- Visual identifiers in the care of people with dementia
2020
- Citizen generated data and health: predictive prevention of disease
- Personalising breast cancer prevention – bridging the gap between research and policy
- The GDPR and genomic data
- Artificial intelligence for genomic medicine
- Black box medicine and transparency
2019
- Our healthy future – a series of reports incl.
- Algorithms as medical devices
- Regulating algorithms in healthcare: the GDPR and IVDR in practice
- Polygenic scores, risk and cardiovascular disease
- Personalising prevention for breast cancer
- Dementia risk prediction
2018
- The personalised medicine technology landscape
- Genomics in mainstream clinical pathways
- Identification and genomic data
2017
- Personalised prevention in breast cancer – the policy landscape
- Developing effective ctDNA testing services for lung cancer
- Linking and sharing routine health data for research
- Variant classification and interpretation – workshop report
- Whole exome sequencing in clinical genetics – a health economic evaluation
- Personalised healthcare: bringing the future into focus
- Delivering improved access to genetic testing in epithelial ovarian cancer
2016
2015
- Data sharing to support UK clinical genetics and genomics services
- Pathogen genomics into practice
- Genetic screening programmes: an international review of assessment criteria
2014
- Realising genomics in clinical practice
- A guide to the investigation of intellectual disability and developmental delay in East Anglia
- Enhanced Genetic Services Project
- Stratified screening for cancer
2013
- Realising genomics in clinical practice (interim report)
- Managing incidental and pertinent findings from WGS in the 100,000 Genomes Project
- Genomics of obesity
2012
2011
- Epidemiology, risk and causation
- Next steps in the sequence
- Quality standards in risk prediction
- Genetics and mainstream medicine: service development and integration
2010
- Public health in an era of genome-based and personalised medicine
- Expanded newborn screening
- Independent response to House of Lords Science and Technology Committee Genomic Medicine report
- Predicting the risk of coronary heart disease with conventional, genetic and novel molecular biomarkers
2009
- Tay Sachs Disease carrier screening in the Ashkenazi Jewish population
- Heart to Heart: inherited cardiovascular conditions services
- Cell-free fetal nucleic acids for non-invasive prenatal diagnosis
2008
- Evidence and evaluation: Building public trust in genetic tests for common diseases
- Genetic ophthalmology in focus
- The evaluation of diagnostic laboratory tests and complex biomarkers
2007
- The evaluation of clinical validity and clinical utility of genetic tests
- Family history as a risk factor for common, complex disease
- Moving beyond ACCE: An expanded framework for genetic test evaluation
2006
- Assessment of the Human Tissue Act
- Evaluation of array-CGH for chromosomal abnormalities in clinical practice
- Learning disability: the interface with genetics
- Biomarkers in familial colorectal cancer screening
- Ethical legal and social issues in stem cell research and therapy – 2nd edition
2005
2004
2003
2001
2000
2025
- The changing nature of diagnosis: background briefing
- AI-driven multiomics in health: our 2025 roundtable insights
- Gene therapy and type 1 diabetes
- Geroscience: reframing ageing research
2024
- Infection and autoimmune disease
- Pathomics, genomics and AI in cancer care
- Regulating Advanced Therapy Medicinal Products in the UK after Brexit
- Electrogenetics – a new avenue in precision medicine
- The federation of trusted research environments for genomics and health
- DNA as data storage
2023
- Optical genome mapping
- Non-coding variants and transcripts for rare disease diagnostics
- Unpacking polygenic scores – a series of policy briefings incl:
- The European Health Data Space
- Host genomics for better infectious disease treatment
2022
- Gene editing animals for organ transplants to humans
- Long-read sequencing: Clinical applications and implementation
- Clinical long-read sequencing
- Precision medicine for inflammatory bowel disease
- Data intermediaries for health
- CAR-T cell therapies
2021
- Phage therapy to treat AMR infections
- Antisense oligonucleotide therapies
- Age-related macular degeneration and genomics
2020
- Functional genomics
- Functional genomics in clinical medicine
- Unpicking the impact of the GDPR on genomic data
- Putting AI to work in genomic medicine
- Black box medicine and transparency
2019
- Somatic genome editing: ethics and regulation
- Somatic genome editing: promise and practicalities
- Citizen generated data – an opportunity for public health?
- Somatic genome editing: an overview
- Citizen generated data: the ethics of remote patient monitoring
- What is an algorithm?
2018
- What is long read sequencing?
- RNA vaccines: an introduction
- Long read sequencing: Ready for the clinic?
- Legal liability for machine learning in healthcare
- What is citizen generated data?
- What is the GDPR?
- What is the IVDR?
2017
- Linking and sharing routine health data for research in England
- ctDNA technology in lung cancer: personalised healthcare in action
2016
- Circulating tumour DNA technology: the future of cancer management?
- Delivering an effective infectious disease genomics service
2015
- Protecting patients from healthcare associated infections: a role for genomics
- Genomics for infection control: meeting local and national needs
- Phenotyping patients for genomic diagnostics
- One health genomics – why animal diseases matter for human health
2014
- Genomics and the management of antimicrobial resistance: current successes and future challenges
- Array CGH testing for learning disability- when is it worth it?
- Sharing clinical genomic data for better diagnostics
- Leading the way: driving the delivery of pathogen genomics into practice
- Setting the right standards for clinical genome analysis
- The impact of genomic sequencing technologies on patient pathways
- Defining the role of a bioinformatician
- Beating the bugs: the pathogen genomics revolution
- Genomics and the boundary between research and clinical care and treatment
- The genomic contribution to diabetes
- Clinical whole genome analysis: delivering the right diagnosis
- ELSI and the implemention of WGS/WES in clinical practice
- AI-driven multiomics in health
- Precision health in a changing climate
- Personalised health: treating the person
- Host genomics: lessons for infectious diseases
- Genome editing: a lot to think about
- Electrogenetics: another tool for precision medicine?
- A look at gene therapy for type 1 diabetes
- Digital twins for health care and research
- Phages: a virus on our side?
- Can long-read sequencing transform genetic diagnosis?
- Polygenic scores – one size does not fit all
- Gene editing animals for organ transplants to humans
- Precision medicine for inflammatory bowel disease
- Liquid biopsies for cancer
2022
2021
- Clinical utility
- Host genomics and infectious disease
- Nutritional genomics
- Pharmacogenomics
- Stem cell therapies
- Vaccinomics
2020
2024
- The 10 year health plan for England
December 2024, NHS England
2022
- Digital transformation in the NHS
June 2022, House of Commons Health and Social Care Committee - Department of Health and Social Care – 10-Year Cancer Plan
April 2022, Department of Health and Social Care - The right to privacy: digital data
January 2022, House of Commons Science and Technology Select Committee
2021
- MHRA Regulation
November 2021, Medicines and Healthcare products Regulatory Agency (MHRA) - Department for Digital, Culture, Media & Sport: Data Protection
November 2021, Department for Digital, Culture, Media and Sport - Nuffield Council of Bioethics consultation – Future of ageing
August 2021, Nuffield Council of Bioethics - MHRA patient and Public Involvement Strategy 2020-25
June 2021, Medicines and Healthcare products Regulatory Agency (MHRA)
2020
- Developing global standards for governance and oversight of human genome editing
August 2020, WHO Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing - Public consultation about the Caldicott Principles and Caldicott Guardians
August 2020, National Data Guardian for Health and Social Care - Response to the EU Commission on a legislative framework for the governance of common European Data Spaces
July 2020, European Union Commission - Project Explain
January 2020, Information Commissioner’s Office
2019
- Advancing our Health: Prevention in the 2020s
October 2019, Department of Health and Social Care - Commercial genomics inquiry
April 2019, House of Commons Science and Technology Select Committee - Review of national cancer screening programmes in England
April 2019, NHS England - National Data Guardian consultation on priorities
March 2019, National Data Guardian for Health and Social Care - Review of the General Medical council consent guidance
January 2019, General Medical Council - Stakeholders consultation on draft AI Ethics Guidelines
January 2019, EU High Level Expert Group on Artificial Intelligence
2018
- Preparing the healthcare workforce to deliver the digital future
September 2018, Health Education England - Developing the long term plan for the NHS
September 2018, NHS England - Consultation on the Centre for Data Ethics and Innovation
September 2018, Department for Digital, Culture, Media and Sport
2017
- Inquiry on using algorithms for decision-making
October 2017, House of Commons Science and Technology Committee - Inquiry on genomics and gene editing in the NHS
October 2017, House of Commons Science and Technology Committee - Inquiry on Artificial Intelligence: evidence
September 2017, House of Lords Select Committee on Artificial Intelligence - Inquiry on Life Sciences and the Industrial Strategy
September 2017, House of Lords Science and Technology Committee - Genome editing open call for evidence – updated response
June 2017, Nuffield Council on Bioethics - Profiling and automated decision-making under GDPR
May 2017, Information Commissioner’s Office - Inquiry into genomics and gene editing
January 2017, House of Commons Science and Technology Committee - Implementation of the rare diseases strategy
January 2017, APPG for Rare, Genetic and Undiagnosed Conditions
2016
- National Data Guardian for health and care’s review of data security, consent and opt-outs
September 2016, Department of Health - The long-term sustainability of the NHS
September 2016, House of Lords Select Committee on the Long-Term Sustainability of the NHS - Call for views and evidence on non-invasive prenatal testing
July 2016, Nuffield Council on Bioethics - Nuffield Council on Bioethics – Genome Editing Open Call for Evidence
January 2016, Nuffield Council on Bioethics - Accelerated Access Review – interim report
January 2016, Accelerated Access Review
2015
- The Big Data Dilemma Inquiry
September 2015, The Science and Technology Committee - Genetic laboratory service redesign
April 2015, NHS England - Nurse review of research councils
April 2015, Department for Business - Investing in specialised services
April 2015, NHS England
2014
- Eurogentest guidelines
December 2014, Eurogentest - Legislation to encourage medical innovation in healthcare
April 2014, Department of Health - Expanded bloodspot screening
March 2014, National Screening Committee - The linking and use of biological and health data
January 2014, Nuffield Council of Bioethics
2013
- Public Health England: Knowledge Strategy
November 2013, Public Health England - Comments on Incidental Findings from the Presidential Commission for the Study of Bioethical Issues
July 2013, Presidential Commission for the Study of Bioethical Issues - Tabled amendments to draft EU regulations on in vitro diagnostic medical devices (IVDDR)
June 2013, European Commission
2012
- The benefits and harms of breast cancer screening
October 2012, Department of Health
2011
- Innovation Review
August 2011, Department of Health - Emerging Biotechnologies
June 2011, Nuffield Council on Bioethics - Healthy Lives, Healthy People
March 2011, Department of Health
2010
- Liberating the NHS consultation
October 2010, Department of Health - Call for evidence on the current data protection legislative framework
October 2010, Ministry of Justice - Revision of Directive 98/79 of the European Parliament and of the Council of 27 October 1998 on In Vitro Diagnostic Medical Devices
June 2010, European Commission - Request for Information on the NIH plan to develop the Genetics Testing Registry (GTR)
June 2010, National Institutes of Health (NIH)
2009
- A Common Framework of Principles for direct-to-consumer genetic testing services
December 2009, Human Genetics Commission - Medical profiling and online medicine: The ethics of ‘personalised’ healthcare in a consumer age
July 2009, Nuffield Council on Bioethics - The framework for the registration of health and adult social care providers and on the draft regulations
May 2009, Department of Health - Regulations to implement the Human Fertilisation and Embryology Act 2008
May 2009, Department of Health
2008
- Consultation on Secondary Uses of Patient Information
May 2009, NHS Connecting for Health - Revised Codes of Practice to the Human Tissue Act
November 2008, Human Tissue Authority - Cell-free fetal DNA for non-invasive prenatal diagnosis
October 2008, House of Lords Science and Technology Committee - Genomic Medicine
April 2008, House of Lords Science and Technology Committee - Consultation on Confidentiality Guidance
February 2008, General Medical Council - NHS Constitution
February 2008, NHS - The amendments to the draft charter for bereaved people
February 2008, Ministry of Justice - Consent in Research
February 2008, General Medical Council - Good Practice Guide in Paternity Testing Services
February 2008, Department of Health - Code of Practice for Genetic Tests
February 2008, Association of British Insurers - Data Sharing Review
February 2008, Ministry of Justice
2007
- Review of the Declaration of Helsinki: Ethical principles for biomedical research involving human beings
November 2007, World Medical Association - Challenges and priorities for the next five years
October 2007, Medicine and Healthcare Products Regulatory Agency - Guidance on nominating a consultee for research involving adults who lack capacity to consent
September 2007, Department of Health
A complete list of our published academic papers can be found on the journal papers page or you can view on their respective author pages.
Visit our news and blog page to keep up to date with our insights and the latest developments in science, policy and health.